scispace - formally typeset
Journal ArticleDOI

Ceramide-orchestrated signalling in cancer cells

Samy A.F. Morad, +1 more
- 01 Jan 2013 - 
- Vol. 13, Iss: 1, pp 51-65
TLDR
This Review focuses on ceramide signalling and the targeting of specific metabolic junctures to amplify the tumour suppressive activities of ceramide.
Abstract
One crucial barrier to progress in the treatment of cancer has been the inability to control the balance between cell proliferation and apoptosis: enter ceramide. Discoveries over the past 15 years have elevated this sphingolipid to the lofty position of a regulator of cell fate. Ceramide, it turns out, is a powerful tumour suppressor, potentiating signalling events that drive apoptosis, autophagic responses and cell cycle arrest. However, defects in ceramide generation and metabolism in cancer cells contribute to tumour cell survival and resistance to chemotherapy. This Review focuses on ceramide signalling and the targeting of specific metabolic junctures to amplify the tumour suppressive activities of ceramide. The potential of ceramide-based therapeutics in the treatment of cancer is also discussed.

read more

Citations
More filters
Journal ArticleDOI

Sphingolipids and their metabolism in physiology and disease.

TL;DR: These results highlight critical roles for bioactive sphingolipids in most, if not all, major cell biological responses, including all major cell signalling pathways, and they link sphingoipid metabolism to key human diseases.
Journal ArticleDOI

Emergence of neural encoding of auditory objects while listening to competing speakers

TL;DR: Recording from subjects selectively listening to one of two competing speakers using magnetoencephalography indicates that concurrent auditory objects, even if spectrotemporally overlapping and not resolvable at the auditory periphery, are neurally encoded individually in auditory cortex and emerge as fundamental representational units for top-down attentional modulation and bottom-up neural adaptation.
Journal ArticleDOI

mTOR signalling and cellular metabolism are mutual determinants in cancer.

TL;DR: The interdependencies of mTOR signalling and metabolism pathways in cancer and how metabolic reprogramming in response to changes in m TOR signalling and vice versa can sustain tumorigenicity are discussed.
Journal ArticleDOI

Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development

TL;DR: The role of aberrant lipid biosynthesis in cancer cell migration and invasion, and in the induction of tumour angiogenesis, is explored.
Journal ArticleDOI

Early olfactory processing in Drosophila: mechanisms and principles.

TL;DR: This review summarizes the neurophysiology of the first two layers of this system: the peripheral olfactory receptor neurons and their postsynaptic targets in the antennal lobe and suggests some general principles with broad relevance to early sensory processing in other modalities.
References
More filters
Journal ArticleDOI

A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors

TL;DR: Reversible dose-dependent hepatic toxicity was seen, as expected from preclinical data, and safingol, the first putative SphK inhibitor to enter clinical trials, can be safely administered in combination with cisplatin.
Journal ArticleDOI

Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase 3 in colon cancer cells

TL;DR: Modulation of CerS6 expression may constitute a new therapeutic strategy to alter apoptotic susceptibility and is suggested to reverse TRAIL resistance in SW620 cells.
Journal ArticleDOI

GSK-3β acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis

TL;DR: A role for GSK-3β is indicated in ceramide-induced apoptosis, in which GSK -3β acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 and caspases-8.
Journal ArticleDOI

Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.

TL;DR: A foundation is established for clinical trials evaluating the efficacy of combining sorafenib with nanoliposomal ceramide for treatment of cancers as well as for mechanistic basis for inhibition.
Related Papers (5)